Accutane contains isotretinoin, also known chemically as 13 cis retinoic acid, a systemic retinoid derived from vitamin A. Isotretinoin is primarily used for the treatment of severe nodular, inflammatory, or treatment resistant acne, particularly when conventional therapies such as topical medications and systemic antibiotics have failed to produce adequate improvement.
Isotretinoin acts on several of the major biological processes involved in acne development. One of its most important effects is a substantial reduction in sebaceous gland size and sebum production. Excess sebum contributes to blocked follicles and creates an environment that promotes inflammation and acne associated bacterial activity. By strongly suppressing sebaceous gland activity, isotretinoin addresses a major underlying factor in severe acne.
Isotretinoin also helps normalize follicular keratinization, reducing the accumulation of skin cells that can block pores and form comedones. Its combined effects on sebum production, follicular obstruction, inflammation, and the follicular environment make it distinct from treatments that address only one aspect of acne.
Unlike many acne medications that primarily control symptoms during active treatment, a completed course of isotretinoin can produce prolonged improvement in some patients. Canadian product information recognizes isotretinoin for severe nodular and inflammatory acne and recalcitrant acne that has not responded adequately to standard therapy.
This product provides:
- Active Ingredient: Isotretinoin
- Strength: 40mg per tablet
- Quantity: 30 Tablets
- Drug Class: Systemic retinoid
- Dosage Form: Oral tablet
Isotretinoin is a prescription medication with significant safety requirements. The most important risk is its extremely high potential to cause severe birth defects if exposure occurs during pregnancy. It must not be used during pregnancy, and strict pregnancy prevention measures and medical monitoring are required for patients who can become pregnant.
Treatment commonly causes dryness of the lips, skin, eyes, and nasal passages. Isotretinoin can also affect blood lipid levels and liver function, which is why laboratory monitoring may be required before and during treatment. Other important adverse effects and precautions are outlined in the prescribing information and should be reviewed with a qualified healthcare professional.
Concurrent use with tetracycline antibiotics should generally be avoided because both drug classes have been associated with intracranial hypertension. Vitamin A supplements should also be discussed with a healthcare professional because combining additional vitamin A with isotretinoin can increase the risk of retinoid related toxicity.
Because 40mg represents a higher individual capsule strength, the appropriate daily dose depends on factors such as body weight, clinical response, adverse effects, and the treatment plan established by the prescribing physician. Isotretinoin should only be taken according to medical direction and should not be shared with another person.
